|
|
Supply of EpiPen® Jr with 30 November 2017 expiry during temporary shortage Mylan Australia (which supplies EpiPens in Australia) is experiencing a temporary shortage of EpiPen® Jr 150mcg adrenaline (epinephrine) autoinjectors. This supply disruption is due to an unforeseen delay in supply from the overseas manufacturer. Mylan expects stock to be available mid-to-late November 2017. In the meantime, to minimise the impact on patient care, Mylan Australia wishes to advise that they will be supplying eligible patients with an EpiPen® Jr, expiring on 30 November 2017, at no charge. Pharmacists with any issues regarding supply of EpiPen® Jr or EpiPen® should contact the Mylan Customer Support team on 1800 274 276. Please note that New Zealand is not affected by this temporary shortage. For more information go to www.allergy.org.au/about-ascia/info-updates/743-epipen-jr-temporary-shortage |
